Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 9.37 Delayed Data As of Aug 21 |  -0.03 / -0.32%Today’s Change | 3.21 Today|||52-Week Range 9.70 | +111.51% Year-to-Date |
| Spectrum (SPPI) Initiates Phase II Study for Cancer Drug Aug 16 / Zacks.com - Paid Partner Content | Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised Aug 08 / Zacks.com - Paid Partner Content |
